New minimally invasive breat cancer treatments are showing positive effects in clinical trials.
CAESAREA, Israel and CLEVELAND, June 4, 2012 /PRNewswire/ -- IceCure Medical Ltd. announced the first four breast cancer patients treated with the IceSense3(TM) Cryoablation Procedure in Japan. The IceSense3 System was used to treat small breast cancer tumors in a minimally invasive procedure using ultrasound guidance and local anesthesia. These patients were the first four enrolled in a clinical trial of 30 small, early stage breast cancer patients at Kameda Medical Center in Kamogawa City, Japan.
Cryoablation has been used for years to treat both malignant and benign tumors in the body. This new system from IceCure Medical has been developed specifically for breast tumors, and can be performed comfortably with ultrasound guidance. The system uses extremely cold temperatures to destroy (ablate) breast tumors. An attractive alternative to open surgery, the IceSense3 procedure takes place in a physician's office or breast center, and doesn't require sutures or general anesthesia. The system is currently being used worldwide for treatment of fibroadenomas, benign breast tumors, and holds promise as a potential treatment option for malignant breast tumors.
"This procedure is an exciting step towards moving treatment of small, early stage breast cancer tumors from open surgery to a minimally invasive cryoablation procedure," stated Eisuke Fukuma, MD, PhD, Chairman of Breast Center, Kameda Medical Center (Kamogawa City, Japan).
Read full story release here: http://www.lef.org/news/LefDailyNews.htm?NewsID=13529&Section=DISEASE